๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Epidemiological Characteristics and Efficacy Evaluation of Difficult-To-Treat Crohn's Disease
NCT07364734Crohn Disease
Xiang Gao
Observational
1,400
Guangzhou
2025-11-01
Recruiting
Deep Learning-Based Multidimensional Body Composition Mapping for Outcome Prediction in HCC Patients Undergoing TACE
NCT07235410Hepatocellular Carcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Observational
300
Wuhan
2025-11-01
Recruiting
Novel CD19/BCMA Dual-Targeted CAR-T Cell Therapy for the Treatment of Relapsed/Refractory Multiple Myeloma
NCT07359014Relapse Multiple Myeloma
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
25
Hangzhou
2025-11-01
Recruiting
Nudge-Based Shared Decision Making and Self-Management in Type 2 Diabetes: A Randomized Trial
NCT07129915Diabetes Mellitus, Type 2, Physician-Patient Relations, Self-management
Yunxuan Li
Not applicable
250
Xiamen
2025-11-01
Not yet open
Effectiveness of Electrical Pudendal Nerve Stimulation for Neurogenic Lower Urinary Tract Dysfunction in Pediatric Tethered Cord Syndrome Post-Surgery
NCT07062133Postoperative Neurogenic Lower Urinary Tract Dysfunction Secondary to Tethered Cord Syndrome
Shanghai Institute of Acupuncture, Moxibustion and Meridian
Not applicable
50
Shanghai
2025-11-01
Recruiting
CONNEctome-guided Navigation for Eloquent-area Tumor Surgery Trial
NCT07657403Brain Neoplasms, Eloquent Area Brain Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not applicable
200
Beijing
2025-11-01
Recruiting
Study of Ultra-Fast CD19 CAR-T Therapy for Refractory SLE
NCT07233642Systemic Lupus Erythematosus
The Children's Hospital of Zhejiang University School of Medicine
Phase 1
18
Hangzhou
2025-11
Not yet open
A Trial of SHR-4658 in Healthy Volunteers or Volunteers With Elevated Blood Pressure
NCT07230145Heart Failure
Beijing Suncadia Pharmaceuticals Co., Ltd
Phase 1
48
Beijing
2025-11
Not yet open
Safety and Efficacy of NK510 to Treat Gastric Cancer and Colorectal Cancer
NCT07166263Gastric Cancer (GC), Colorectal Cancer
Base Therapeutics (Shanghai) Co., Ltd.
Phase EARLY_PHASE1
15
Nanjing
2025-11
Not yet open
Sacubitril/Allisartan for Hypertensive Patients With Overweight or Obesity
NCT07241338Hypertension
Jing Liu
Phase 4
104
Beijing
2025-11
Not yet open
A Phase II Clinical Study Evaluating SSGJ-706 in Combination Therapy for Advanced Gastrointestinal Cancers
NCT07233850Gastric/Gastroesophageal Junction Adenocarcinoma, Metastatic Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC), Oesophageal Cancer
Shenyang Sunshine Pharmaceutical Co., LTD.
Phase 2
300
Wuhan
2025-11
Not yet open
Evaluation of the Efficacy and Safety of TQB2825 Injection Compared to Immunotherapy in the Treatment of Recurrent/Refractory Follicular Lymphoma
NCT07187960Follicular Lymphoma
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Phase 3
228
Beijing, Chongqing, Lanzhou, Guangzhou, Guiyang, Haikou, Harbin, Zhengzhou
2025-11
Recruiting
Non-Invasive Fundus Retinal Detection Technology for Early Diagnosis of Parkinson's Disease
NCT07244640Parkinson's Disease (PD)
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
200
Hangzhou
2025-11
Not yet open
Dexmedetomidine-Esketamine Combination for Sedation and Analgesia in ICU Patients
NCT06468436Aged, Intensive Care Units, Ventilators, Mechanical, Dexmedetomidine
Peking University First Hospital
Not applicable
1,508
Beijing, Tianjin
2025-11
Not yet open
Open-Label, Biomarker-Integrated Umbrella Trial for First-Line Treatment of Extensive-stage Small Cell Lung Cancer
NCT07172412Extensive Stage Lung Small Cell Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2
165
Tianjin
2025-11
Recruiting
AD-SVF Therapy for Refractory Endometrial Infertility
NCT07230600Endometrium; Atrophy, Intrauterine Synechiae
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 1
10
Nanjing
2025-11
Not yet open
A Clinical Study Evaluating the Safety, Tolerability, Preliminary Efficacy and Immunogenicity of a Tumor Vaccine Injection Targeting Stressinducible Proteins MICA/B in Combination With the AG Regimen in Patients With Metastatic Pancreatic Cancer
NCT07231094Pancreatic Cancer Metastatic
The Third Xiangya Hospital of Central South University
Phase EARLY_PHASE1
13
Hunan
2025-11
Not yet open
Fengliao Changweikang for Diarrhea-predominant Irritable Bowel Syndrome: N-of-1 Trial
NCT07061184Irritable Bowel Syndrome - Diarrhoea, Traditional Chinese Medicine (TCM), N of 1 Study Design, Efficacy and Safety
Peking Union Medical College Hospital
Phase 4
50
Beijing
2025-11
Not yet open
A Phase III Study of NTQ5082 Capsules in the Treatment of Paroxysmal Nocturnal Hemoglobinuria Patients
NCT07177859Paroxysmal Nocturnal Hemoglobinuria
Nanjing Chia-tai Tianqing Pharmaceutical
Phase 3
78
Tianjin
2025-11
Recruiting
Postoperative Delirium in Patients Undergoing Cardiac Surgery
NCT07239648Postoperative Delirium
Xijing Hospital
Observational
1,500
Xi'an
2025-10-31
Recruiting
Prevention of Delayed CINV After Autologous Transplant: Olanzapine-Containing Regimen vs. Dexamethasone-Containing Regimen
NCT07413809Multiple Myeloma
The Affiliated People's Hospital of Ningbo University
Phase 3
92
Ningbo
2025-10-31
Recruiting
A Clinical Trial of SIBP-A10 Injection in the Treatment of Advanced Malignant Tumor Subjects.
NCT07205198Advanced Tumors
Shanghai Institute Of Biological Products
Phase 1
160
Dalian
2025-10-31
Recruiting
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
NCT07291037Non-small Cell Lung Cancer (NSCLC)
AstraZeneca
Phase 3
400
Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou
2025-10-31
Recruiting
Efficacy and Safety Phase II Study of VC005 Tablets in Subjects With Non-segmental Vitiligo
NCT07172347Non-segmental Vitiligo
Jiangsu vcare pharmaceutical technology co., LTD
Phase 2
120
Beijing
2025-10-31
Recruiting
Evaluation of the Safety and Effectiveness of CHORDSยฎ Cerebral Protection System During TAVR: DUET Trial
NCT07648693Transcatheter Aortic Valve Replacement (TAVR), Cerebral Vascular Accident (CVA)/Stroke
Resonova (Shanghai) Medtech Limited
Not applicable
240
Bengbu, Hefei, Beijing, Chongqing, Fuzhou, Guangzhou, Nanchang, Qingdao
2025-10-31
Recruiting
Golidocitinib With PD-1 Inhibitors as Maintenance Treatment for Previously Untreated ES-SCLC
NCT07110103SCLC, SCLC, Extensive Stage
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
20
Beijing, Chongqing
2025-10-31
Active, closed
HRS-7450 Injection Phase II Clinical Trial for Acute Ischemic Stroke.
NCT07233070Acute Ischemic Stroke
Fujian Shengdi Pharmaceutical Co., Ltd.
Phase 2
210
Guangzhou, Linyi
2025-10-31
Recruiting
To Evaluate The Safety and Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress Syndrome
NCT07208591Acute Respiratory Distress Syndrome (ARDS)
Staidson (Beijing) Biopharmaceuticals Co., Ltd
Phase 3
406
Beijing, Xiamen, Guangzhou, Zunyi, Luoyang, Zhengzhou, Wuhan, Xiangtan
2025-10-31
Recruiting
A Digitally-Enabled System for Precision Assessment and Intervention of Disability Risk in Older Adults
NCT07508813Disability
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
238
Hangzhou
2025-10-31
Recruiting
Camrelizumab and Apatinib With or Without FOLFOX Chemotherapy for Advanced HCC
NCT07267806Hepato Cellular Carcinoma (HCC), Chemotherapy Effect
Linhui Peng
Phase 3
326
Guangzhou
2025-10-31
Recruiting
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
NCT07223593Peripheral Arterial Disease
Eli Lilly and Company
Phase 3
1,205
Beijing, Chengdu, Guangzhou, Harbin, Luoyang Shi, Nanjing, Shanghai, Tianjin
2025-10-31
Not yet open
The Effects of Clostridium Butyricum on Adverse Events During Adjuvant Chemotherapy for Colorectal Cancer
NCT07152886Colorectal Cancer, Chemotherapeutic Toxicity
The Affiliated Hospital of Qingdao University
Phase 4
238
Qingdao
2025-10-31
Recruiting
A Study of AND017 to Evaluate Efficacy and Safety in Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Patients With Anemia
NCT07494409Anemia Due to Chronic Kidney Disease
Kind Pharmaceuticals LLC
Phase 3
300
Shanghai
2025-10-31
Recruiting
A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer
NCT07205822Breast Cancer
AstraZeneca
Phase 3
100
Beijing, Changsha, Guangzhou, Linyi, Shandong, Wuhan, Zhengzhou
2025-10-30
By invitation
A Single-Arm Study on the Efficacy of Sequential Chemoradiotherapy Followed by Surgery in Adult Nasal and Paranasal Sinus Rhabdomyosarcoma
NCT07449949ORR, PFS, OS
Eye & ENT Hospital of Fudan University
Observational
43
Shanghai
2025-10-30
Recruiting
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
NCT07173751Breast Neoplasms
BioNTech SE
Phase 3
558
Changde, Hefei, Jinan, Lanzhou, Linyi, Nanchang, Nanjing, Neijiang
2025-10-30
Recruiting
Auricular Stimulation for Functional Dyspepsia With Insomnia: Efficacy and Mechanisms
NCT07442734Functional Dyspepsia, Insomnia, Brain and Nervous System
The First Affiliated Hospital of Zhejiang Chinese Medical University
Not applicable
176
Hangzhou
2025-10-30
Not yet open
A Prospective, Single-center, Phase II Study of Sacituzumab Tirumotecan in Combination With Pembrolizumab for Neoadjuvant Treatment of Triple-Negative Breast Cancer (TNBC)
NCT07054242Neoadjuvant Therapy, Stage II to III (T1cN1-2 or T2-4N0-2) TNBC Breast Cancer
Yantai Yuhuangding Hospital
Phase 2
52
Yantai
2025-10-30
Recruiting
Adebrelimab With Famitinib and Chemotherapy as Neoadjuvant Therapy for ESCC
NCT07796113Esophageal Squamous Cell Carcinoma
First Affiliated Hospital Xi'an Jiaotong University
Phase 2
24
Xi'an
2025-10-30
Recruiting
QL1706 Combined With Chemotherapy in the Treatment of Immune-mediated NSCLC
NCT07330596NSCLC (Advanced Non-small Cell Lung Cancer)
Anhui Provincial Cancer Hospital
Phase 2
96
Hefei
2025-10-30
Recruiting
A Study of SHR-A2009 Combined With Aumolertinib Versus Aumolertinib for First-line Treatment in EGFR-mutated, Advanced or Metastatic NSCLC
NCT07183189Non-small Cell Lung Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 3
576
Guangzhou
2025-10-30
Active, closed
Serplulimab, Chidamide, and Rituximab Followed by Sequential R-CHOP for Newly Diagnosed Elderly MYC/BCL2 Double-Expressor DLBCL
NCT07538180Newly Diagnosed MYC/BCL2 Double-expressor DLBCL
Sun Yat-sen University
Phase 2
30
Guangzhou
2025-10-30
Not yet open
A Prospective๏ผŒSingle Arm, Multicenter Clinical Study of BTLA Monoclonal Antibody JS004 (B/T Lymphocyte Attenuator Factor Monoclonal Antibody) in Combination With Toripalimab in Patients With Unresectable or Advanced Renal Cell Carcinoma Who Had Failed Previous Immunotherapy
NCT06730932Unresectable or Advanced Clear Cell Renal Cell Carcinoma That Has Progressed After Previous Immunotherapy
RenJi Hospital
Phase 2
31
Shanghai
2025-10-30
Recruiting
A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults.
NCT07219615Chronic Spontaneous Urticaria
Pfizer
Phase 2
200
Beijing, Guangzhou, Shijiazhuang, Shanghai, Tianjin, Hangzhou
2025-10-30
Recruiting
A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis
NCT07201051Bronchiectasis
GlaxoSmithKline
Phase 2
363
Beijing, Chongqing, Dongguan, Guangzhou, Guilin, Hangzhou, Huizhou, Jiangmen
2025-10-30
Recruiting
Letermovir Prophylaxis Duration Guided by CMV-Specific T-cell Monitoring After Allo-HSCT.
NCT07569653Cytomegalovirus Infections, Cytomegalovirus Disease, Hematopoietic Stem Cell Transplantation, Graft vs Host Disease
WeiShi
Phase 4
120
Beijing, Shijiazhuang, Zhengzhou, Jingzhou, Wuhan, Hohhot, Nanchang, Wenzhou
2025-10-30
Recruiting
F182112 Phase Ib Clinical Study for the Treatment of Patients With Systemic Lupus Erythematosus
NCT07829614Systemic Lupus Erythematosus (SLE)
Shandong New Time Pharmaceutical Co., LTD
Phase 1
64
Shanghai
2025-10-30
By invitation
Comparison of Accuracy of Full-arch Implant Digital and Conventional Impressions.
NCT07190820Edentulous Jaw
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Not applicable
24
Shanghai
2025-10-30
Recruiting
Impact of Airway Mucus Plugs on Secondary Pulmonary Fibrosis in COPD Patients: A Single-Center Case-Control Study
NCT07236541Lung Fibrosis
Ming Zhong
Observational
20
Shanghai
2025-10-30
Not yet open
An Exploratory Study of Golidocitinib in Adult Patients With ITP
NCT07196163Immune Thrombocytopenia (ITP)
Peking University People's Hospital
Phase 1/2
138
Beijing
2025-10-30
Not yet open
An Exploratory Study of Near-infrared Light Therapy for Mild to Moderate Alzheimer's Disease
NCT06836180Alzheimer Disease
Xuanwu Hospital, Beijing
Phase EARLY_PHASE1
40
Beijing
2025-10-30
Not yet open
A Clinical Study to Explore CT1194D in Patients With Relapsed/Refractory B-Cell Neoplasms
NCT07200479Relapsed/Refractory B-Cell Neoplasms
Institute of Hematology & Blood Diseases Hospital, China
Phase 1
20
Tianjin
2025-10-30
Recruiting
Dynamic Airway Resistance & ML: Guide Sputum Suction in Ventilated Patients
NCT07375667Mechanical Ventilation Pressure High, Ventilator-Associated Pneumonia (VAP), Respiratory Depression Neonatal
Affiliated Hospital of Nantong University
Not applicable
258
Bengbu, Beijing, Hangzhou
2025-10-30
Recruiting
BPC2001 for the Prevention of Acute Graft-Versus-Host Disease Following Haploidentical Stem Cell Transplantation
NCT07246031Graft -Versus-host-disease, aGVHD, Haploidentical Stem Cell Transplantation, cGVHD
BioPhoenix Co., Ltd.
Phase 2
50
Beijing, Wuhan
2025-10-29
Recruiting
Phase 2 Study of Kylo-11 in ASCVD Patients With Elevated Lp(a)
NCT07327840Lipoprotein Disorder
Kylonova (Xiamen) Biopharma co., LTD.
Phase 2
204
Beijing, Baotou, Changchun, Changde, Changsha, Chengdu, Chongqing, Dali
2025-10-29
Recruiting
A Study of YL201 and Ivonescimab (AK112) in Advanced Solid Tumors
NCT07208773Advanced Solid Tumors, Non Small Cell Lung Cancer, Small Cell Lung Cancer
MediLink Therapeutics (Suzhou) Co., Ltd.
Phase 1/2
260
Guangzhou
2025-10-29
Recruiting
Study of GC012F, CAR-T Therapy Targeting CD19 and BCMA in Chinese Participants With Relapsed or Refractory AL Amyloidosis
NCT07250269Relapsed/Refractory AL Amyloidosis
Gracell Biotechnologies (Shanghai) Co., Ltd.
Phase 1
9
Beijing, Changchun, Guangzhou, Hangzhou, Suzhou, Wenzhou, Wuhan
2025-10-29
Recruiting
Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Trial to Evaluate the Efficacy and Safety of HRS-9813 in Subjects With Pulmonary Fibrosis
NCT07192939IPF and PPF
Guangdong Hengrui Pharmaceutical Co., Ltd
Phase 2
270
Beijing
2025-10-29
Active, closed
A Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus Given to Chinese Adults 18 to 59 Years of Age at Increased Risk of Respiratory Syncytial Virus Disease
NCT07220109Respiratory Syncytial Virus Infections
GlaxoSmithKline
Phase 3
750
Beijing, Xiangtan, Nanjing, Chengdu, Chongqing, Guangzhou, Jiujiang, Kunming
2025-10-29
Recruiting
A Study of Ivonescimab in First-Line ES-SCLC
NCT07245446Extensive-stage Small Cell Lung Cancer (ES-SCLC)
Akeso
Phase 2
180
Beijing, Xi'an, Shanghai
2025-10-29
Recruiting
A Study of HRS-4508 in Combination With Other Anti-tumor Therapy for Solid Tumor
NCT07140393Solid Tumor
Jiangsu HengRui Medicine Co., Ltd.
Phase 1/2
120
Beijing
2025-10-28
Recruiting
Study to Evaluate the Efficacy and Safety of Adjuvant Tislelizumab in High-Risk Stage I NSCLC
NCT07120282Lung Cancer (NSCLC)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
108
Beijing
2025-10-28
Recruiting
Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment
NCT07139366Gastritis, Dyspepsia, Helicobacter Pylori Infection, Gastric Cancer
Yongquan Shi
Phase 4
1,248
Xi'an
2025-10-28
Recruiting
QL1706 Plus Chemotherapy as Neoadjuvant Therapy for Locally Advanced Cervical Cancer: A Phase II Trial
NCT07286253Neoadjuvant Treatment for Locally Advanced Cervical Cancer
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Phase 2
50
Guangzhou
2025-10-28
Recruiting
Population Pharmacokinetics and Pharmacodynamics of Ciprofol
NCT07301242Hip Fractures (ICD-10 72.01-72.2), Osteoarthritis, Knee and Hip, Femoral Neck Fractures
Shanghai Geriatric Medical Center
Observational
50
Shanghai
2025-10-28
Recruiting
Clinical Study of O&D-001 Injection in the Treatment of Relapsed or Refractory Multiple Myeloma
NCT07369895Relapsed or Refractory Multiple Myeloma
O&D BioTech Group CO., Limited
Phase 1
18
Guangzhou
2025-10-28
Recruiting
To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of GB18 Injection in Healthy Participants
NCT07237464Cancer Cachexia (CC), Cancer Cachexia, Cancer Cachexia Syndrome
Shenzhen Kexing Pharmaceutical Co., Ltd.
Phase 1
36
Beijing
2025-10-28
Recruiting
A Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial Fibrillation
NCT07217067Atrial Fibrillation
Novartis Pharmaceuticals
Phase 2
165
Beijing, Xi'an
2025-10-28
Recruiting
Safety and Efficacy of ZZSW-01 in Relapsed/Refractory B-cell Malignancies
NCT07240974Relapsed/Refractory B-cell Malignancies
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase EARLY_PHASE1
6
Wuhan
2025-10-28
Recruiting
Nalbuphine Timing Effects on Hemodynamics and Analgesia in Elderly Patients
NCT07271849Postoperative Pain, Acute, Hemodynamics, Total Knee Arthroplasty (TKA)
Qianfoshan Hospital
Phase 4
162
Jinan
2025-10-28
Recruiting
GT719 Injection for Moderate to Severe Refractory Autoimmune Disease
NCT07132112Auto Immune Disease
Grit Biotechnology
Phase EARLY_PHASE1
30
Nantong
2025-10-28
Active, closed
Research on the Effectiveness of Remote Rehabilitation l for Shoulder and Neck Recovery in Oral Cancer Patients After Selective Neck Dissection
NCT07504809Oral Cancer Patients After Selective Neck Dissection
Pai Pang
Not applicable
80
Shenyang
2025-10-28
By invitation
To Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Food Effects of LY03021 in Healthy Chinese Subjects
NCT07371065Major Depressive Disorder
Luye Pharma Group Ltd.
Phase 1
98
Shanghai
2025-10-28
Recruiting
A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combined With Chemotherapy in Lung Cancer
NCT07381829Advanced Solid Tumor Cancer
HC Biopharma Inc.
Phase 1
328
Guangzhou
2025-10-27
Not yet open
A Phase 2 Study to Evaluate the Efficacy, Safety of SIM0278 in Subjects With Moderate to Severe Atopic Dermatitis
NCT07175233Atopic Dermatitis (AD)
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 2
184
Hangzhou, Shenyang
2025-10-27
Active, closed
A Translational Study for Phenotyping and Endotyping Chinese Patients With NCFBE
NCT07245407Non-cystic Fibrosis Bronchiectasis
AstraZeneca
Observational
251
Beijing, Chongqing, Quanzhou, Lanzhou, Shenzhen, Zhanjiang, Nanning, Guiyang
2025-10-27
Recruiting
UB-VV410 in Subjects With Active Refractory Systemic Lupus Erythematosus or Lupus Nephritis
NCT07109986Systemic Lupus Erythematosus, Lupus Nephritis
Nanjing IASO Biotechnology Co., Ltd.
Phase 1
21
Nanjing
2025-10-27
Recruiting
A Phase 1/2 Study of PRO-203 in Healthy Volunteers and Participants With Systemic Sclerosis.
NCT07641634Healthy Volunteers, Systemic Sclerosis (SSc), Scleroderma, Systemic, Scleroderma
Prolium Bioscience, Inc
Phase 1/2
44
Beijing, Guangzhou, Nanchang, Nanjing, Pingxiang
2025-10-27
Active, closed
Organotypic Platform for Therapeutic Investigation (OPTin) for Guiding Cancer Patients Treatment
NCT07468422Cancer Patients With Solid Tumors, Cancer (Advanced Stage)
China Medical University Hospital
Observational
200
2025-10-27
Recruiting
Efficacy and Safety of Intrathecal Administration of Thiotepa in Combination With Trastuzumab in Breast Cancer With Leptomeningeal Metastasis
NCT07263425Leptomeningeal Metastasis of HER2-positive Breast Cancer
The First Affiliated Hospital with Nanjing Medical University
Phase 2
26
Nanjing
2025-10-27
Active, closed
A Phase โ…  b Clinical Study of ART101 Injection
NCT07614308Hypertension (HTN)
Arnatar Therapeutics, Inc.
Phase 1
16
Suzhou
2025-10-27
Recruiting
Confirmatory Clinical Study of HEC585 Tablets in Patients With IPF
NCT07082842Idiopathic Pulmonary Fibrosis (IPF)
Sunshine Lake Pharma Co., Ltd.
Phase 3
472
Beijing
2025-10-27
Recruiting
Genetic Risk Score of Type 1 Diabetes Mellitus for Progression to Insulin in Diabetic Patients Lack of Predictive Value: a Multicenter Nested Case-control Study
NCT07621445Diabetes Mellitus, Diabetes Mellitus, Type 1
Second Xiangya Hospital of Central South University
Observational
2,950
Changsha
2025-10-27
Recruiting
SCRT Followed by AK112 in pMMR/MSS Mid-low Rectal Cancer
NCT07162714Rectal Cancer, Radiation, AK112
Zhejiang Cancer Hospital
Phase 2
30
Hangzhou
2025-10-27
Recruiting
Study on Ketorolac for Improving Outcomes and Prognosis in Patients With Stanford Type A Aortic Dissection
NCT06968806Aortic Dissection, Inflammation
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 3
1,346
Nanjing
2025-10-27
Recruiting
Multimodal Deep Learning for Postoperative Liver Cancer Risk Stratification and Intervention
NCT07282184Hepotacellular Carcinoma
Tongji Hospital
Phase 1/2
144
Wuhan
2025-10-26
Recruiting
A Clinical Study of BAT4406F Injection in Patients With Minimal Change Disease/Focal Segmental Glomerulosclerosis
NCT07499700Minimal Change Disease (MCD), Focal Segmental Glomerulosclerosis (FSGS)
Bio-Thera Solutions
Phase 2/3
192
Beijing
2025-10-26
Recruiting
Neoadjuvant Zanidatamab + Tislelizumab + Chemotherapy for Selective Bladder Preservation in HER2-Positive MIBC
NCT07296705Muscle Invasive Bladder Cancer (MIBC)
Fujian Medical University Union Hospital
Phase 2
25
Fuzhou, Putian, Quanzhou, Sanming, Xiamen, Zhangzhou, Nanchang, Jinan
2025-10-25
Recruiting
Stereotactic Thrombolysis With Tenecteplase for Supratentorial Intracerebral Hemorrhage
NCT07208097Intracerebral Haemorrhage, Minimally Invasive Treatment
Tongji Hospital
Not applicable
768
Suzhou, Guiyang
2025-10-25
Recruiting
RGL-270 + ICI in Advanced NSCLC
NCT07652125NSCLC
Guangdong Association of Clinical Trials
Not applicable
40
Guangzhou
2025-10-25
Recruiting
Application Effects of Wrist-Ankle Acupuncture in Patients With Different Types of Pain Following Perianal Surgery
NCT07340307Wrist-Ankle Acupuncture
The Affiliated Hospital of Putian University
Not applicable
58
Putian
2025-10-25
Recruiting
Determination of the Effective Dose of a Single Intravenous Dose of Tegileridine Fumarate for Postoperative Analgesia After Orthopedic Surgery: A Up-and-Down Sequential Allocation Study
NCT07353996Postoperative Pain
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 4
180
Hanzhong
2025-10-25
Recruiting
TrIal of Early Minimally Invasive Catheter Evacuation With Thrombolysis in IntraCerebral Hemorrhage
NCT07187687Intracerebral Hemorrhage
Xuanwu Hospital, Beijing
Not applicable
750
Guangdong, Baotou, Beijing, Bozhou, Changsha, Changzhi, Changzhou, Chifeng
2025-10-24
Recruiting
Orelabrutinib as Consolidation and Maintenance Therapy in Treatment-Naรฏve MZL.
NCT07372365Marginal Zone Lymphoma (MZL)
The First Affiliated Hospital of Soochow University
Phase 2
23
Suzhou
2025-10-24
Recruiting
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
NCT06793215Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Hoffmann-La Roche
Phase 3
600
Nanchang, Beijing, Changsha, Chengdu, Hangzhou, Harbin, Jinan, Nantong
2025-10-24
Recruiting
Functional Lung Avoidance Radiotherapy Guided by 4DCT Pulmonary Ventilation Function Imaging: A Prospective Single-arm Clinical Study
NCT07339644Lung Cancer (Including Metastatic Cancer), Radiation Pneumonitis, Radiation-induced Lung Injury
The Second Affiliated Hospital of Chongqing Medical University
Not applicable
100
Chongqing
2025-10-24
Recruiting
A Study of QLC5508 Combinations in Patients With Advanced Solid Tumors
NCT07256782Advanced Solid Tumor
Qilu Pharmaceutical Co., Ltd.
Phase 1/2
444
Shanghai
2025-10-24
Recruiting
A Phase โ…ก/โ…ข Study of HRS-2129 for Postsurgical Pain Management in Abdominal Surgery
NCT07185594Postoperative Analgesia
Shandong Suncadia Medicine Co., Ltd.
Phase 2/3
360
Zhengzhou, Hangzhou
2025-10-24
Recruiting
Combination of COMBO Endoscopy Oropharyngeal Airway and HFNC Oxygenation in Sedated Gastrointestinal Endoscopy for Morbidly Obese Patients
NCT07175155Hypoxemia, Esophageal Cancer, Morbidly Obese Patients, Gastric Cancer
Zhejiang University
Not applicable
410
Beijing, Jinjiang, Hangzhou, Lishui, Taizhou
2025-10-24
Active, closed
ClinicAL outComes of IntraVascular Lithotripsy Combined With Conventional Lesion Preparation in Patients With Moderate to Severe Coronary Artery Calcification
NCT07340294Coronary Artery Calcification, Calcific Coronary Arteriosclerosis
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
1,096
Nanchang, Shenyang, Hangzhou, Tianjin
2025-10-24
Rows per page Showing 5501–5600 of 19052
Previous 54 55 56 57 58 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 22 September 2026. https://priyalifescience.com/clinical-trials-china?page=56

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.